Safety of proteasome inhibitors for treatment of multiple myeloma.
about
"Neurological complications of new chemotherapy agents".Living with Relapsed Myeloma: Symptoms and Self-care Strategies.Cardiovascular adverse events in modern myeloma therapy - incidence and risks. A review from European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesisCovalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer
P2860
Safety of proteasome inhibitors for treatment of multiple myeloma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Safety of proteasome inhibitors for treatment of multiple myeloma.
@en
Safety of proteasome inhibitors for treatment of multiple myeloma.
@nl
type
label
Safety of proteasome inhibitors for treatment of multiple myeloma.
@en
Safety of proteasome inhibitors for treatment of multiple myeloma.
@nl
prefLabel
Safety of proteasome inhibitors for treatment of multiple myeloma.
@en
Safety of proteasome inhibitors for treatment of multiple myeloma.
@nl
P2093
P2860
P1476
Safety of proteasome inhibitors for treatment of multiple myeloma.
@en
P2093
Danielle Schlafer
Elyse Hall Panjic
Katherine S Shah
P2860
P304
P356
10.1080/14740338.2017.1259310
P407
P50
P577
2016-11-14T00:00:00Z